Figure 3 — Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy

Research Paper|Volume 15, Issue 17|pp. 8664–8691

Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy

Back to articleFigure 3(3 of 8)

100%

Figure 3.Associations between KIAA1429 expression and tumor mutational burden (TMB), microsatellite instability (MSI). (A) Correlations between KIAA1429 expression and TMB in pan-cancer. (B) Correlations between KIAA1429 expression and MSI in pan-cancer.